Nemes Rush Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Sell |
26,733
-294
| -1% | -$13.6K | 0.13% | 91 |
|
|
2025
Q1 | $1.65M | Hold |
27,027
| – | – | 0.21% | 70 |
|
|
2024
Q4 | $1.53M | Buy |
27,027
+221
| +0.8% | +$12.5K | 0.19% | 70 |
|
|
2024
Q3 | $1.45M | Sell |
26,806
-18
| -0.1% | -$976 | 0.21% | 73 |
|
|
2024
Q2 | $1.11M | Buy |
26,824
+18
| +0.1% | +$748 | 0.15% | 81 |
|
|
2024
Q1 | $1.45M | Buy |
26,806
+31
| +0.1% | +$1.68K | 0.21% | 73 |
|
|
2023
Q4 | $1.37M | Sell |
26,775
-702
| -3% | -$36K | 0.22% | 75 |
|
|
2023
Q3 | $1.59M | Sell |
27,477
-2,491
| -8% | -$145K | 0.29% | 70 |
|
|
2023
Q2 | $1.92M | Buy |
+29,968
| New | +$1.92M | 0.34% | 61 |
|